News 2024年 05月 06日 EY reports growth of 53 percent for investments in Switzerland Foreign investments in Europe fell by 4 percent in 2023. However, investments in Switzerland were up by 53 percent. These findings were reported ...
News 2024年 04月 30日 Top Stories from Western Switzerland (April 2024) From biotech breakthroughs and the transformation of clinical trials to advancements in eco-friendly materials and renewable energy initiatives, ...
Actualités 2024年 04月 30日 Les Grands Titres de Suisse occidentale (Avril 2024) De percées biotechnologiques à la transformation des essais cliniques, en passant par des avancées dans le domaine des matériaux écologiques et d...
Actualités 2023年 09月 29日 Les Grands Titres de Suisse occidentale (Juillet-Septembre 2023) De l'élaboration de solutions éco-innovantes à des avancées pionnières dans les domaines de la technologie solaire, de la recherche sur le cancer...
News 2024年 01月 10日 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
News 2023年 09月 29日 Top Stories from Western Switzerland (July-September 2023) From spearheading eco-innovative solutions to pioneering breakthroughs in solar technology, cancer research, sustainable shipping, and the realms...
News 2023年 08月 14日 Bern’s thriving ecosystem for life sciences innovation In the heart of Western Switzerland, the canton of Bern has emerged as a location of choice for companies in the life sciences sector.
News 2023年 03月 08日 Oculis lists on Nasdaq with strong clinical-stage pipeline in ophthalmology Oculis Holding AG, a global biopharmaceutical company focused on saving sight and improving eye care, has announced its listing on the Nasdaq sto...
News 2023年 01月 18日 Calciscon enters Eurostars project to improve patient care worldwide Calciscon, together with Amsterdam University Medical Centers and ADMESY, have signed a collaborative agreement for the development of a laborato...
News 2022年 11月 23日 Geneva biopharma ObsEva sells its Ebopiprant license for up to USD 113 million Women's and reproductive health specialist ObsEva has announced the sale of its license for ebopiprant to California-based biotech company Xoma f...
News 2021年 10月 27日 ONWARD Medical goes public and raises CHF 93 million EPFL spin-off ONWARD Medical went public on Euronext Brussels with a secondary listing on Euronext Amsterdam, bringing the value of the company t...
News 2022年 02月 22日 Digital neurotherapeutics specialist MindMaze secures USD 105 million MindMaze has closed a USD 105 million financing round to accelerate its global commercial growth plans, supercharge ongoing R&D and consolidate t...
News 2022年 02月 01日 Merck acquires Geneva-based biopharmaceutical company Chord Therapeutics Chord Therapeutics, a clinical stage biopharmaceutical company developing drugs for rare neuroinflammatory diseases, is being acquired by Merck.
News 2021年 10月 19日 Loop Medical raises USD 6.4 million to conquer US market Vaud-based healthcare start-up Loop Medical has completed a USD 6.4 million Series A financing round for its innovative blood collection device.
News 2021年 10月 12日 Neurotherapeutics pioneer MindMaze secures USD 125 million MindMaze, a global pioneer in the digital neurotherapeutics market, raised USD 125 million from AlbaCore Capital Group. This brings the Vaud-base...
Aktuell 2024年 05月 06日 EY meldet Plus von 53 Prozent bei Investitionen in der Schweiz Ausländische Investitionen in Europa sind 2023 um 4 Prozent gesunken. Die Investitionen in der Schweiz sind dagegen um 53 Prozent gestiegen. Das ...
News 2021年 05月 11日 Vaud-based ophthalmic treatments specialist Oculis raises $ 57 million A biopharmaceutical company focused on developing innovative ophthalmic treatments, Oculis has announced the closing of an oversubscribed $ 57 mi...